Online Submissions

Already have a Username/Password for Malignant tumours?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

Author Guidelines

Preparing the article, authors should be guided by the following rules that take into account Uniform Requirements for Manuscripts Submitted to Biomedical Journals developed by the International Committee of Medical Journal Editors.

1. General rules

In the journal there will be published the results only of studies performed in compliance with the rules of biomedical ethics and GCP (Good Clinical Practice) standards.

All the authors of the article should be included in the first correspondence with the editorial staff. The author identified as the formal corresponding author is responsible for all feedback with the editorial staff (see item 2).

After sending the article via the form on the website, the first author must also additionally confirm by an information letter to the editorial board of the journal "Malignant Tumors" (plykina@russco.org) that all authors of the article have read its content and have no additional comments. In this case, the article must be attached to the letter, and all authors must be in a copy of the letter to the editorial board.

In order to consider a manuscript, the editorial staff requires written consent of each author for processing and distribution of personal data (Download form to fill out) in printed and digital format. A scan of the signed consent form must be uploaded as an attached file in the Description section when submitting your article. Send the printed signed paper consent to the editorial office: RUSSCO, 25/1, Trubnaya str., Moscow 127051, Russia. To the editorial office of Malignant Tumors Journal.

2. Article and author information

Title page should include:

• article title;
• authors’ names (first and middle name initials, full surname);
• full names of their departments/institutions where work was carried out (full addresses with postcodes);
• e-mail address of the corresponding author.

For example:

Drug treatment of metastatic pancreatic cancer

I.I. Ivanov¹, I.I. Petrov²

1. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; 23 Kashirskoe Shosse, Moscow 115478, Russiа;

 2. Oncology Center No. 1 of the City Clinical Hospital named after S. S. Yudin of the Moscow Department of Health; 18A Zagorodnoe Shosse, Moscow 117152, Russia

Contacts: Ivan Ivanovich Ivanov ivanov@mail.ru

Last page should include:

1) information about the corresponding author:

• full name (first, middle and surname);
• position held;
• graduate degree;
• international personal identifier ORCID (more info: http://orcid.org/);
• personal identifier in RINC system (more info: http://elibrary.ru/projects/science_index/author_tutorial.asp);
• phone number.

2) information about each of the other authors:

• full name (first, middle and surname);
• position held;
• graduate degree;
• ORCID (if any);
• e-mail address.

3. Style

Articles are accepted in DOC, DOCX, RTF format. Font – Times New Roman, size 14, 1.5 space. All pages should be numbered.

To highlight text, use italics or bold, but not underline (except for Internet addresses).

4. Word count (excluding figures/tables and references)

Original article:

- an expanded format for presenting the results of a logically complete scientific study;

- from 3000 to 6000 words, 3-8 figures/tables/graphs, at least 20 references;

- not greater than 12 pages (larger volume is allowed on an individual agreement with the editorial board).

Review articles:

- a critical summary of a research topic;

- 3000 words or more, 3 or more figures/tables/graphs, at least 40 references;

- no more than 20 pages.

Clinical cases:

- an expanded format for presenting a real clinical case (including a literature review, discussion questions, diagnostic search, treatment and follow-up, discussion);

- from 2000 words or more, from 2-3 or more figures/tables/graphs, at least 10 references;

- no more than 8 pages. 

5. Abstract

Abstract in Russian and English (preferably) are required. Should be presented on a separate page. Abstract should briefly repeat structure of the article, regardless of its subject.

No more than 2500 characters, including spaces. Summary should not contain references and illustrations.

Keywords: 3 to 10 keywords in Russian and English (if possible) should be presented below the abstract.

6. Article structure

Research article should consist of the following sections:

• introduction;
• materials and methods;
• results;
• discussion;
• conclusion;
• acknowledgments (section is optional).

In addition, in accordance with the rules of Scopus and PubMed, the article should contain:

• contributions of all authors (see item 6.2.1);
• conflict of interest (see item 6.2.2);
• source of funding (see item 6.2.3);
• approval of the study protocol by Ethics Committee (for original studies) (see item 6.2.4);
• informed consent of patients (for original studies and reviews of clinical cases) (see item 6.2.4);
• compliance with principles of bioethics (for study using laboratory animals) (see item 6.2.4).

The above data should be given after the list of references.

6.1 Article Sections

Original articles

Introduction. The section reveals the relevance of the study based on the literature reference, highlights the state of the issue with references to the most significant publications. At the end of the introduction, the goal is formulated, reflecting the need to conduct the study.

Materials and methods. Details of the study methods, inclusion criteria, study design, statistical analysis. The presented methods should ensure the possibility of reproducing the results of the study. Values of the measurements must comply with the International System of Units (SI). When referring to an equipment and/or drugs used in the study one should indicate manufacturer and country of origin in the brackets; when listing drugs and chemicals one should specify their international nonproprietary (common) name, dose, administration route.

If required by the study conditions, please specify Ethics Committee that had approved it; as well as the fact of signing the informed consent by the participants.

Results. Presented clearly in the form of short descriptions of the results of their own research with references to graphs, tables and figures, without references to literary sources, without elements of discussion, without repetition of methodological details, without duplication of digital data presented in tables and figures.

Discussion. Selection of new and important aspects of the results of the study, analysis of possible mechanisms and results interpretation. If possible, comparison of own results with other studies. An inclusion of evidence-based recommendations in clinical practice and application of the data obtained in the future studies is mostly welcome.

Avoid repetition of information in the section “Introduction” and detailed data listing from the section “Results”.

Conclusion. Should be short and concise (no more than 1 paragraph). Summing up the work done and hypothesis of the authors on the data significance in the framework of pathogenesis, treatment, diagnosis; prospects for the use of the obtained data.

Review articles

A review article should contain an analysis of the literature on a relevant topic with a presentation of modern sources (mainly for the last 7 years). Abstracts of review articles should contain information on methods for searching literature in the Web of Science, Scopus, MedLine, The Cochrane Library, Russian Science Citation Index and other databases. The bibliography should contain references to highly cited articles from Web of Science and Scopus.

Clinical cases

A report on a rare clinical case of interest. The clinical case should be well illustrated and contain a discussion of the issue using literature data.

6.2 Ethics and additional article attributes

6.2.1 Authorship and authors’ contributions

According to the recommendations of the ICMJE, the right to be referred as the author have those persons who made significant contribution to the conception and design of the study or in the data analysis and its interpretation, actively participated in drafting the article or making fundamental changes, participated in the final approval of the version that is to be published and ready to take responsibility for the contents of the article.

The first in the list of authors should be the head of the research team that took the greatest part in the work and preparation of the article. He should also be a corresponding author (who is responsible for communication with the editorial staff and readers after the publication of the article). When approving the final version of the article, the corresponding author should make sure that all co-authors have seen it and approved it for publication.

The sole provision of funding, provision of laboratory materials and tools, technical article editing, scientific advice or general management of the research team do not justify inclusion in the group of authors.

An example of information about the contribution of the authors:
Authors’ contributions

I.I. Ivanov: collection data, article editing;

А.А. Petrov: data collection and processing, concept and design of the study;

I.А. Sidorov: writing the article, statistical processing.

Persons who played a different role in the preparation of the article (statisticians, language specialists, technical staff, etc.) may be listed in the "Acknowledgments" section of the article in Russian and English. For example:

Acknowledgments

The authors express their gratitude to I.I. Ivanov, MD, Head of Department, for significant comments and key advice during the research and preparation of this article.

6.2.2 Conflict of interest

At the end of the article you must specify conflicts of interest for all authors. Conflict of interest implies the existence of any relations and/or personal interest that potentially can affect results, interpretation of data, its objective perception, such as financial relations and cooperation with any organizations (e.g., receipt of fees, educational grants, participation in expert councils, membership, work relations, consulting work, ownership of a shop in a private property or other interests) or non-financial interest (e.g., personal or professional relationships, acquaintance and so on) concerning issues discussed in the article and/or materials.

If there is no conflict of interest, please specify the following statement at the end of the article:
Conflict of interest
Authors declare no conflict of interest.

6.2.3 Research funding

It is necessary to indicate whether the work received financial support, and the source of funding (grant, company support, etc.). For example:

Financing. The study was performed without external funding.

Financing. The study was performed with the support of Company name.

Financing. The study was supported by the Russian Science Foundation (grant No. 23‑49‑22-001).

6.2.4 Patient rights and principles of bioethics

For the original study, it is necessary to specify Ethics Committee that had approved it (indicating the number of the document, the date of its signing and the official name of Committee).

Patients have a right to protect their privacy that is not to be disclosed without their consent. Information that allows personification (including patient names, initials, numbers of hospitals and medical case histories should not be published in form of written descriptions, photographs, and pedigrees unless this information has a great scientific value, or if the patient (its parents or guardians) will not provide a written consent to the publication. In this case, authors should inform patients whether there is likelihood that the material, which allows personification will be available via the Internet after publication. Authors should submit written patients informed consent to the editorial board for distribution of information and report about it in the article:

If patients are under 18 years old:

If the article includes a review of clinical case:

When using laboratory animals for the study, it is necessary to indicate whether the study protocol complied with all standards for conducting biomedical research involving animals:

7. Measurement units and abbreviations

Units are provided in the International System of Units (SI). If the study was carried out by using devices that provide measurements in other units, you need to convert them to SI system with an indication of the conversion factor, or software version in “Materials and methods”.

Abbreviations are not allowed, except for those that are generally accepted. All abbreviations in text of the article must be fully decrypted at the first mention (e.g., neuromuscular disease (NMD)).

Gene name should be specified in italics, protein name – in normal font.

 Illustrative material

Illustrative materials include photographs, figures, images, diagrams, graphs, charts, tables. Files of illustrative material should be able to reproduce high-quality images in the electronic and printed versions of the journal. If data from any other source are used – published or unpublished, the author is obliged to provide permission for their use and cite the source in the legend, otherwise it will be considered as plagiarism and the publication will not be accepted.

Number of illustrations should match the volume of the information in the text.

Illustrative material should be submitted as a separate files and should be accompanied by links in the appropriate places in the text of the article, references should be in round brackets, e.g., (fig. 1), (table 1).

Photos are submitted in TIFF, JPG format with a resolution of at least 300 dpi (dots per inch). If the photo is small (for example, 3 ×4 cm), you should choose a resolution of 1200 dpi when scanning. Eyes of the patients or healthy subjects on photos are to be masked. If not, the author should submit patient's written permission.

Figures, images, graphs, charts, diagrams are presented in Microsoft Office Excel or Office Word format. If you cannot provide them in this format, please contact the editorial staff.

All figures must be numbered and provided with captions in Russian and English. All inscriptions in figures, images, graphs, charts, diagrams should be translated into English too.

Fragments of figure should be presented as lower-case letters in Russian – “a”, “b”, etc. All abbreviations, symbols in form of curves, letters, numbers, etc., used in the figure should be decrypted in caption. Captions are given on a separate page after main text of the article in one file with it.

Tables should be ostensive, have the title and serial number. Graph headers should correspond to their content. All abbreviations are explained in the footnote to the table. You need to specify statistical method used for analysis and corresponding confidence value (p). All information contained in the table, including its title and notes, should be translated into English. If table sizes exceed one typewritten page, they are provided as a separate file in DOC, DOCX, RTF format.

9. References

The article must be accompanied by a list of references, formatted as follows:

• Reference sources are given in order of citation. All references must be numbered, numbering is carried out strictly as the citations occur in text;
• for each source, you must specify: names and initials of the author  (if there are more than 4 authors, the first 3 authors are listed, then “et al.”);
• when referring to articles from journals, you must indicate the title of the article, the name of the journal, year, volume, issue number, pages, as well as PMID (a unique article code in PubMed) and DOI (if available). You can find the DOI index on the website http://search.crossref.org or on the article page in PubMed;
• when referring to monographs, it is also necessary to indicate the full title of the book, place of publication, name of the publisher, year of publication, number of pages;
• when referring to dissertation abstracts, it is also necessary to indicate the full title of the work, whether it is a doctoral or candidate's dissertation, year, place of publication, number of pages;
• when referring to data obtained from the Internet, you must provide the full email address of the cited source;
• All references in the text, tables should be identified by Arabic numerals in square brackets, e.g. [5];

References should be to the original sources and not to quote one review where they are mentioned. References to unpublished works, as well as data obtained from unofficial Internet sources, are not allowed.

The number of references: preferably not more than 20–25 in the research article, not more than 60 in the review article.

References should be made as follows:

Journal article

Matsko MV, Matsko DE, Imyanitov EN, et al. Embryonal tumors of the central nervous system in adults. Siberian Journal of Oncology. 2021;20(1):105–14. doi:10.21294/1814-4861-2021-20-1-105-114 (In Russ.)

Patent

Sanarova E.V., Lantsova A.V., Barishnikova M.A. et al. Antitumor agent. The patent of the Russian Federation No 2569729. 16.03.2018 (in Russ.).

Internet resource

Vetrov P.N., Kolosov А.D., Bolotin Yu.М. et al. Surgical treatment of metastatic gastric cancer. Available at: http://www.oncologiya.ru/articles/articles_15_72.htm.

10. General provisions

• Review of the articles for publication takes at least 8 weeks.
• All incoming articles are reviewed. Review is anonymous. Correspondence with the reviewer is carried out by executive secretary. After final decision on acceptance or rejection of the work, all authors will receive an information letter with notification on reading.
• Editorial board reserve the right to edit articles submitted for publication.
• If you find errors in the article prior to publication, or in case when editor informs the author that he had received information from a third party on some errors in the article, the author is obliged to cooperate with the editor of the journal for the purpose of early withdrawal of articles from the layout and its fixing.
• If errors are found after publication of the journal, author also is obliged to cooperate with the editor and follow its instructions in order to address the problem individually.
• Editorial board does not provide author's copies of the journal. Number of the journal can be obtained on a general basis, see information on the website.
• All articles, including those prepared by graduate students and applicants for the scientific degree of candidate of sciences on the results of their own studies are accepted for publication free of charge.

Articles should be sent to the address: 25/1, Trubnaya str., Moscow 127051, Russia. To the editorial office of Malignant Tumors Journal, E-mail: journal@russco.org

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

1. This article has not been published, nor submitted for review and publication in the other journal (or it was mentioned in the Comments to the editor).

2. The article is presented in the file of the OpenOffice, Microsoft Word, RTF or WordPerfect document.

3. Full web addresses (URL) are provided for the references where possible.

4. The text is typed 1.5 line spacing; using 14 font size; to highlight something the italic type of letters is used rather than underlining (except for Internet addresses).

5. The text corresponds to the stylistic and bibliographic requirements contained in the Guidelines for the authors at the “About the journal” page. 

Copyright Notice

Authors who publish with this journal agree to the following terms:

1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Privacy Statement

Specified when registering the names and addresses will be used solely for technical purposes of a contact with the Author or reviewers (editors) when preparing the article for publication. Private data will not be shared with other individuals and organizations.